Stock Events

Microbot Medical 

$1.03
26
+$0.04+4.05% Today

Statistics

Day High
1.04
Day Low
-
52W High
2.47
52W Low
0.86
Volume
120,157
Avg. Volume
225,433
Mkt Cap
16.44M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

15MayConfirmed
Q2 2022
Q3 2022
Q4 2022
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-0.51
-0.4
-0.28
-0.17
Expected EPS
-0.17
Actual EPS
-0.17

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MBOT. It's not an investment recommendation.
Alphabet
68918
GOOGL
Apple
60554
AAPL
Microsoft
56693
MSFT
Amazon
51850
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Intuitive Surgical
ISRG
Mkt Cap161.39B
Intuitive Surgical is a leading developer of robotic-assisted surgical systems, directly competing with Microbot Medical's robotic technologies aimed at improving clinical outcomes.
Medtronic
MDT
Mkt Cap101.91B
Medtronic offers robotic-assisted surgery solutions, competing in the same space as Microbot Medical with its innovative medical devices for minimally invasive procedures.
Smith & Nephew
SNN
Mkt Cap12.37B
Smith & Nephew provides advanced surgical robotics for orthopedic procedures, competing with Microbot Medical in the broader field of robotic-assisted surgeries.
Zimmer Biomet
ZBH
Mkt Cap22.73B
Zimmer Biomet Holdings, Inc. competes in the development of robotic solutions for orthopedic surgeries, a market that overlaps with Microbot Medical's target for their robotic devices.
Stryker
SYK
Mkt Cap129.88B
Stryker Corporation specializes in medical technologies, including robotic surgery systems, making it a competitor in the robotic-assisted surgical market alongside Microbot Medical.
Johnson & Johnson
JNJ
Mkt Cap372.29B
Johnson & Johnson, through its subsidiary Ethicon, is involved in the development of surgical robotics, competing with Microbot Medical's innovations in the same domain.
Boston Scientific
BSX
Mkt Cap114.03B
Boston Scientific Corporation offers products that compete in the minimally invasive medical device market, including endoscopy and interventional cardiology, areas where Microbot Medical also aims to innovate.
Abbvie
ABBV
Mkt Cap304.29B
AbbVie, while primarily known for its pharmaceuticals, has ventured into medical devices and robotics through acquisitions, indirectly competing with Microbot Medical's focus on robotic surgical solutions.
Alphabet
GOOGL
Mkt Cap2.24T
Alphabet Inc., through its Verily life sciences division, is exploring robotic surgery and other medical technologies, making it a potential future competitor in the innovative medical robotics space where Microbot Medical operates.

Analyst Ratings

7$Average Price Target
The highest estimate is $7.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

About

Health Technology
Biotechnology
Manufacturing
Biological Product (except Diagnostic) Manufacturing
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
Show more...
CEO
Harel Gadot
Employees
21
Country
US
ISIN
US59503A2042
WKN
000A2N5AS

Listings

F
DE
CY9D.F
XNAS
US
MBOT